Health, Wellness, & Intravenous Hydration Provider

Description:
The Company is a premier multi-location luxury IV therapy health and wellness medical spa providing IV therapy, peptide therapy, vitamin injections, medical weight loss programs, hormone replacement therapy (HRT), and medical aesthetics.

Key Aspects:
• The Company averaged over $1 million in adjusted EBITDA from 2022 to 2023
• From 2022 to 2023, the Company’s gross profit (GP) margin averaged 80.4%
• In 2023, the average monthly recurring revenue for the Company was approximately $341k
• Facility design plan in place for expansion efforts created by a world-renowned design and architecture firm
• Immediate synergistic upside from a high influx of unique visitors due to large attractions nearby
• Well-established and published as the #1 provider of IV therapy for successive years in its local region

Opportunities:
• Capitalize on the scheduled opening of two locations in 2024
• Maximize growth potential by introducing medical aesthetics services at all locations
• Continue to grow monthly subscriptions to drive recurring revenue
• Expand the service area to include larger metropolitan areas outside of the current operational footprint

Headquartered:
• Southeast, US

Current Markets:
• The Company serves individuals seeking health and wellness services in the Southeast, United States.

Real Estate:
• The Company operates from four facilities totaling approximately 5,950 sq. ft., each encompassing a reception & waiting area, laboratory space, exam rooms, and therapy chairs. Additionally, the Company leases two additional locations scheduled to open in 2024. All six facilities are leased from unrelated third parties and are relocatable.

Shareholder Ownership:
• The Company is owned by two shareholders who want to pursue other interests. Both shareholders are willing to remain with the Company in an advisory role for a predetermined period to facilitate a smooth transition to new ownership. The Company has a succession plan in place with a key employee.